| VEXAS syndrome: A new mimicker of idiopathic multicentric Castleman disease R Philip, V Cadro, A Aouba, S Chantepie, C Bracquemart, A Dumont Joint Bone Spine 91 (4), 105731, 2024 | | 2024 |
| Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia Y Chalandon, P Rousselot, S Chevret, JM Cayuela, R Kim, F Huguet, ... Blood 143 (23), 2363-2372, 2024 | 1 | 2024 |
| Decitabine in Older Patients with AML: Quality of Life Results of the EORTC-GIMEMA-GMDS-SG Randomized Phase III Trial F Efficace, M Kicinski, C Coens, S Suciu, WJFM van der Velden, ... Blood, 2024 | | 2024 |
| Devimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trial TS Pardee, BL Powell, RA Larson, J Maly, M Keng, M Foster, EJ Choi, ... Blood Neoplasia 1 (2), 100009, 2024 | | 2024 |
| Efficacy of eculizumab in transplantation-associated thrombotic microangiopathy: results of the French nationwide study on behalf of the SFGM-TC and the CNR-MAT M Peyre, F Sicre de Fontbrune, A Berceanu, L Benjemia, M Castelle, ... Bone Marrow Transplantation, 1-3, 2024 | | 2024 |
| Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire S Villar, S Chevret, X Poire, M Joris, P Chevallier, JH Bourhis, E Forcade, ... Bone Marrow Transplantation, 1-9, 2024 | | 2024 |
| Communications orales 04 Leucémies aiguës: clinique et biologique T Marchand, MA Hospital, M Heiblig, S Chantepie, M Carre10, ... Hématologie 30 (2), 222, 2024 | | 2024 |
| IDALLO study: A retrospective multicenter study of the SFGM‐TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1‐mutated AML after allogeneic hematopoietic cell … A Caillet, M Simonet‐Boissard, E Forcade, M Robin, MT Rubio, ... HemaSphere 8 (3), 2024 | | 2024 |
| Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10 … E Brissot, M Labopin, H Labussière, G Fossard, P Chevallier, T Guillaume, ... Blood Cancer Journal 14 (1), 31, 2024 | 4 | 2024 |
| Pneumocystis pneumonia after allogeneic hematopoietic cell transplantation: a case-control study on epidemiology and risk factors on behalf of the infectious diseases working … C Robin, C Cordonnier, G Tridello, N Knelange, A Xhaard, S Chantepie, ... Transplantation and Cellular Therapy 30 (2), 235. e1-235. e10, 2024 | 2 | 2024 |
| Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry C Lacan, J Lambert, E Forcade, M Robin, P Chevallier, S Loron, ... Journal of Hematology & Oncology 17 (1), 2, 2024 | 2 | 2024 |
| Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study C Orvain, S Chantepie, X Thomas, M Escoffre-Barbe, F Huguet, ... Haematologica 108 (12), 3287, 2023 | 2 | 2023 |
| Comparison of Two Reduced Intensity Conditioning Regimens (Baltimore with Clofarabine vs Thiotepa-Busulfan-Fludarabine) in Adults Receiving Peripheral Blood Stem Cell … M Jullien, R Dulery, E Daguindau, M Loschi, A Bazarbachi, ... Blood 142, 3530, 2023 | | 2023 |
| CPX-351 in Patients with Newly Diagnosed post myeloproliferative neoplasms acute myeloid leukemia S Garciaz, A Belhabri, R Guieze, L Goursaud, P Peterlin, MP Ledoux, ... Blood 142, 2917, 2023 | | 2023 |
| Allogeneic Hematopoietic Cell Transplantation in the Elderly Results in Similar Survival with Matched Related or Unrelated and Haploidentical Donors: A Report from the Société … I Ahmad, S Harbi, R Devillier, C Castilla-Llorente, M Robin, M Srour, ... Blood 142, 3604, 2023 | | 2023 |
| Pooled Fecal Allogenic Microbiotherapy for Refractory Gastrointestinal Acute Graft-Versus-Host Disease: Results from Early Access Program in Europe F Malard, M Loschi, T Cluzeau, F Legrand, JB Méar, F Lhomme, A Huynh, ... Blood 142, 3553, 2023 | | 2023 |
| Current Results of Intensive Therapy in Younger Adults with Acute Myeloid Leukemia (AML): The Large Randomized French Backbone Intergroup (BIG)-1 Study on Behalf of the Filo … HB Mathilde, C Pautas, S Bertoli, PY Dumas, E Raffoux, T Marchand, ... Blood 142, 967, 2023 | 1 | 2023 |
| Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study from the Société Francophone De Greffe De Moelle Et … Y Chalandon, R Devillier, A Boumendil, SN Quoc, CE Bulabois, ... Blood 142, 2235, 2023 | | 2023 |
| Mutational Profile and Dynamics of PPM1D-Mutant Clones in the Spectrum of Myeloid Disorders J Pegliasco, D Fandrei, F Pasquier, N Ibrahim, M Kfoury, ... Blood 142, 4064, 2023 | | 2023 |
| Checkpoint Inhibitors and Allo-SCT in Hodgkin Lymphoma: A Matter of Time-a Study By the SFGM-TC E Kaphan, F Bettega, D Michonneau, MCM De Oca, N Fegueux, M Robin, ... Blood 142, 4926, 2023 | | 2023 |
